Use of the thrombin generation test to evaluate response to treatment with recombinant activated factor VII.
Dargaud
Yesim
Y
Clinical Hemostasis Unit, Hôpital Edouard Herriot, Lyon, France. ydargaud@aol.com
Bordet
Jean-Claude
JC
Lienhart
Anne
A
Negrier
Claude
C
D001780:Blood Coagulation Tests; D015942:Factor VIIa / Q000008:administration & dosage*; D006467:Hemophilia A / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D053657:Platelet-Rich Plasma / Q000378:metabolism; D011994:Recombinant Proteins / Q000008:administration & dosage; D013917:Thrombin / Q000378:metabolism
D011994:Recombinant Proteins; C103587:recombinant FVIIa; D015942:Factor VIIa; D013917:Thrombin